Paul Stoffels, J&J’s chief scientific officer, told ABC’s “This Week” that Johnson & Johnson is increasing its manufacturing and preparing for clinical trials in September. He hopes to have data and start developing the vaccines at the end of the year. Source: The Hill, 10/5/2020